CCCC · C4 Therapeutics, Inc. · Executive Compensation
$2.48
+0.04 (+1.64%)
At close · Nov 20
Return incl. dividend (before tax)
Market Cap
$325.67M
Shares
131.32M
Volume · Nov 20
3.63M
Avg daily vol (3M)
2.55M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Andrew J. Hirsch | President & Chief Executive Officer | $2,940,975 |
| Leonard Reyno | Chief Medical Officer | $1,641,798 |
| Kendra R. Adams | Chief Financial Officer | $1,476,789 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Andrew J. Hirsch | President & Chief Executive Officer | $5,239,784 |
| Leonard Reyno | Chief Medical Officer | $2,314,100 |
| Kendra R. Adams | Chief Financial Officer | $2,197,489 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Andrew J. Hirsch | President & Chief Executive Officer | $3,790,099 |
| Leonard Reyno | Chief Medical Officer | $1,674,727 |
| Stewart Fisher | Chief Scientific Officer | $1,533,917 |
| Kendra R. Adams | Chief Financial Officer | $1,210,598 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Scott N. Boyle | Chief Business Officer | $3,914,000 |
| Stewart Fisher | Chief Scientific Officer | $3,104,878 |
| Andrew J. Hirsch | President & Chief Executive Officer | $2,595,395 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Lauren A. White | Chief Financial Officer | $4,085,603 |
| Stewart Fisher | Chief Scientific Officer | $3,788,874 |
| Adam S. Crystal | M.D., Ph.D. Chief Medical Officer | $3,564,503 |
| Jolie M. Siegel | Chief Legal Officer & Secretary | $3,375,441 |
| Andrew J. Hirsch | President & Chief Executive Officer | $952,200 |
| William T. McKee | Former Chief Financial Officer | $348,403 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Andrew J. Hirsch | President & Chief Executive Officer | $20,931,971 |
| Marc A. Cohen | Interim Chief Executive Officer | $9,132,899 |
| William T. McKee | Former Chief Financial Officer | $2,099,745 |
| Adam S. Crystal | M.D., Ph.D. Chief Medical Officer | $1,603,320 |
| Stewart Fisher | Chief Scientific Officer | $1,589,693 |
| Andrew Phillips | Former President & Chief Executive Officer | $618,275 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Andrew Phillips | Former President & Chief Executive Officer | $4,193,675 |
| Adam S. Crystal | M.D., Ph.D. Chief Medical Officer | $1,689,946 |
| Stewart Fisher | Chief Scientific Officer | $465,753 |
| Marc A. Cohen | Interim Chief Executive Officer | — |
| Andrew J. Hirsch | President & Chief Executive Officer | — |
| William T. McKee | Chief Financial Officer | — |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Kendra R. Adams | principal accounting officer | Appointed | 2026-05-15 |
|
Bruce Downey
“Mr. Downey’s decision not to stand for reelection was not due to any disagreements with the Company on any matter relating to the Company’s strategy, operations, policies or practices.”
|
director | Retired | 2025-04-14 |
| Steven L. Hoerter | director | Appointed | 2024-11-20 |
| Paige Mahaney, Ph.D. | Chief Scientific Officer | Appointed | 2024-10-15 |
|
Stewart Fisher, Ph.D.
“Dr. Fisher's retirement and pending departure from the Company was not because of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.”
|
Chief Scientific Officer | Retired | 2024-10-15 |
| Stephen Fawell, Ph.D. | director | Appointed | 2024-09-03 |
|
Malcolm Salter
“There are no disagreements between Mr. Salter and the Company on any matter relating to the Company's operations, policies or practices.”
|
Director | Resigned | 2024-09-03 |
| Bruce Downey | Chair of the Board | Resigned | 2024-06-10 |
| Ron Cooper | Chair of the Board | Appointed | 2024-06-10 |
| Ron Cooper | director | Appointed | 2024-06-10 |
|
Glenn Dubin
“There are no disagreements between Mr. Dubin and the Company on any matter relating to the Company’s operations, policies or practices.”
|
Board of Directors | Resigned | 2024-06-10 |
| Owen P. Hughes, Jr. | director | Appointed | 2023-11-20 |
| Mark Mossler | Chief Accounting Officer and principal accounting officer | Appointed | 2023-09-05 |
| Kendra Adams | Chief Financial Officer, Treasurer and principal financial officer | Appointed | 2023-09-05 |
|
Lauren White
“Ms. White’s resignation was not because of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices, including accounting principles and practices.”
|
Chief Financial Officer, Treasurer, principal financial officer and principal accounting officer | Resigned | 2023-09-05 |
| Hagop Youssoufian, M.D. | interim Chief Medical Officer | Appointed | 2023-02-02 |
| Adam S. Crystal, M.D., Ph.D. | Chief Medical Officer | Resigned | 2023-02-02 |
| Donna Grogan, M.D. | director | Appointed | 2022-08-02 |
| Laura Bessen, M.D. | director | Appointed | 2022-08-02 |
|
Elena Prokupets, Ph.D.
“The resignation was not due to any disagreements with the Company on any matter relating to the Company's operations, policies or practices.”
|
director | Resigned | 2022-03-16 |
| Utpal Koppikar | director | Appointed | 2022-03-16 |
| William T. McKee | interim principal accounting officer | Appointed | 2021-05-20 |
| Laura J. Wahlberg | VP, Finance and Corporate Controller and principal accounting officer | Resigned | 2021-05-20 |
| Lauren White | Chief Financial Officer and treasurer | Appointed | 2021-05-20 |
| Laura J. Wahlberg | Vice President, Finance, Corporate Controller and Principal Accounting Officer | Resigned | 2021-04-30 |
Leadership
- Andrew J. Hirsch CEO
- Andrew Phillips CEO
- Ron Cooper Chairman, Board Member
- Kendra R. Adams CFO, Chief Accounting Officer
- Lauren White CFO, Chief Accounting Officer
- Mark Mossler Chief Accounting Officer
- William T. McKee Chief Accounting Officer
- Adam S. Crystal Board Member
- Donna Grogan, M.D. Board Member
- Laura Bessen, M.D. Board Member
- Owen P. Hughes, Jr. Board Member
- Stephen Fawell Board Member
- Stephen Fawell, Ph.D. Board Member
- Steven L. Hoerter Board Member
- Utpal Koppikar Board Member
Key facts
CIK
1662579
CUSIP
12529R107
13F (30d)
159 filings
142 filers
Visit website
Investor relations